In the recent study, Orthovoltage X-Rays Exhibit Increased Efficacy Compared with γ-Rays in Preclinical Irradiation, researchers found that a dose reduction is necessary for X-rays to achieve comparable biological effects.
See more below and the original study here.
Loading Viewer...
Contact Us
SPOTLIGHT: Translating and Optimizing Experimental Design from Caesium to X-Ray Based Irradiators Transitioning your lab’s irradiation capabilities is a significant undertaking. The primary concern for any researcher making the switch from Caesium to X-ray is...
Access the highly anticipated Xstrahl SPOTLIGHT Session, "Behind the Beam: Tips, Tricks, and Translational Research from the Karolinska Institutet X-ray Irradiation Core Facility," on demand now. This essential recording is a must-watch for radiation researchers and...
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
